1396554-49-6 Usage
General Description
2-Amino-5-bromophenyl methyl sulphone is an organic compound with the molecular formula C7H8BrNO2S. It is a sulphone derivative and contains an amino group, a bromine atom, and a methyl group attached to a phenyl ring. This chemical is commonly used in organic synthesis and pharmaceutical research as a building block for the creation of various compounds. It is also known for its potential use in the development of drugs and organic materials with specific properties. However, it is important to handle this chemical with care as it may pose health and environmental hazards if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 1396554-49-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,9,6,5,5 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1396554-49:
(9*1)+(8*3)+(7*9)+(6*6)+(5*5)+(4*5)+(3*4)+(2*4)+(1*9)=206
206 % 10 = 6
So 1396554-49-6 is a valid CAS Registry Number.
1396554-49-6Relevant academic research and scientific papers
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 001233; 001236; 001324, (2018/05/15)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
4,5,6,7-TETRAHYDRO-1 H-PYRAZOLO[4,3-C]PYRIDIN-3-AMINE COMPOUNDS AS CBP AND/OR EP300 INHIBITORS
-
, (2016/06/14)
The present invention relates to compounds of formula (I) or formula (II): and to salts thereof, wherein R1-R4 of formula (I) and R1-R3 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.